Hill-Rom Holdings Inc. (HRC) Reaches New 1-Year High at $59.74
Hill-Rom Holdings Inc. (NYSE:HRC)’s share price hit a new 52-week high during trading on Monday . The stock traded as high as $59.74 and last traded at $59.51, with a volume of 289,993 shares trading hands. The stock had previously closed at $59.26.
Several equities analysts have commented on HRC shares. Bank of America Corp. reiterated a “buy” rating and set a $69.00 price target on shares of Hill-Rom Holdings in a report on Monday, May 2nd. Morgan Stanley restated a “hold” rating on shares of Hill-Rom Holdings in a research note on Tuesday, May 3rd. KeyCorp restated a “buy” rating and issued a $59.00 price objective on shares of Hill-Rom Holdings in a research note on Thursday, June 23rd. Finally, Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research note on Tuesday, August 9th. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $61.50.
The company has a 50-day moving average of $54.64 and a 200 day moving average of $50.59. The stock has a market capitalization of $3.89 billion and a PE ratio of 61.15.
Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Thursday, August 4th. The medical technology company reported $0.81 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.05. The firm earned $655.40 million during the quarter, compared to the consensus estimate of $647.75 million. The company’s revenue was up 38.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.62 EPS. Equities analysts predict that Hill-Rom Holdings Inc. will post $3.33 EPS for the current year.
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.